US Stock Market Move | Diabetes treatment technology achieves major breakthroughs. Sana Biotechnology (SANA.US) surged more than 232%.

23:09 08/01/2025

On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52.

On Wednesday, Sana Biotechnology (SANA.US) surged over 232%, reaching $5.52. In terms of news, Sana Biotechnology released positive data on its investigational treatment for Type 1 diabetes. The company stated that it transplanted its therapy, UP421, which utilizes a low-immunogenicity biological material core therapy, to a Type 1 diabetes patient who was not using any immunosuppressive drugs. The study did not find any safety issues, and the low-immunogenicity modified core therapy evaded immune reactions.

PLATEAU TL (08402) announced its annual performance with a net loss of 3.6579 million Singapore dollars for shareholders, an increase of 237.45% from the previous year.

GLORY FLAME (08059) released its annual performance report, reporting a net loss of HKD 15.409 million for shareholders, a 24.22% increase compared to the previous year.

GUDOU HLDGS (08308) released its annual performance, with a net loss attributable to shareholders of 61.932 million yuan, an increase of 21.89% year-on-year.

PLATEAU TL (08402) announced its annual performance with a net loss of 3.6579 million Singapore dollars for shareholders, an increase of 237.45% from the previous year.

GLORY FLAME (08059) released its annual performance report, reporting a net loss of HKD 15.409 million for shareholders, a 24.22% increase compared to the previous year.

GUDOU HLDGS (08308) released its annual performance, with a net loss attributable to shareholders of 61.932 million yuan, an increase of 21.89% year-on-year.